Cantor Fitzgerald last night downgraded Korro Bio (KRRO) to Neutral from Overweight without a price target after the company’s lead asset KRRO-110 failed. Cantor now sees a “long journey ahead” for Korro.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KRRO: